<SEC-DOCUMENT>0001564590-21-022601-index.html : 20210430
<SEC-HEADER>0001564590-21-022601.hdr.sgml : 20210430
<ACCEPTANCE-DATETIME>20210430170729
ACCESSION NUMBER:		0001564590-21-022601
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210430
DATE AS OF CHANGE:		20210430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		21879485

	BUSINESS ADDRESS:	
		STREET 1:		4747 EXECUTIVE DRIVE, SUITE 240
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4747 EXECUTIVE DRIVE, SUITE 240
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>ljpc-10ka_20201231.htm
<DESCRIPTION>10-K/A
<TEXT>
Document 1 - file: ljpc-10ka_20201231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ljpc-ex311_33.htm
<DESCRIPTION>EX-31.1
<TEXT>
Document 2 - file: ljpc-ex311_33.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ljpc-ex312_32.htm
<DESCRIPTION>EX-31.2
<TEXT>
Document 3 - file: ljpc-ex312_32.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ljpc-ex321_30.htm
<DESCRIPTION>EX-32.1
<TEXT>
Document 4 - file: ljpc-ex321_30.htm

</DOCUMENT>
</SEC-DOCUMENT>